Stephen B. Fox

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

Elgene Lim, François Vaillant, Di Wu et al. · Nature Medicine · 2009 · 1.5K citations

Medicine, Genetics, Oncology +16

Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

Richard W. Tothill, Anna V. Tinker, Joshy George et al. · Clinical Cancer Research · 2008 · 1.5K citations

Medicine, Gynecology, Oncology +17

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study

D. Ross Camidge, Yung‐Jue Bang, Eunice L. Kwak et al. · The Lancet Oncology · 2012 · 1.3K citations

Medicine, Oncology, Pharmacology +15

<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

Kathryn Alsop, Sián Fereday, Cliff Meldrum et al. · Journal of Clinical Oncology · 2012 · 1.2K citations · Full text

Medicine, Genetics, Oncology +17

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

Gaynor J. Bates, Stephen B. Fox, Han Cheng et al. · Journal of Clinical Oncology · 2006 · 1.2K citations

Life Sciences, Immunology, Oncology +17